Ocean Biomedical, Inc.
OCEA· OTC
OCEAOcean Biomedical, Inc.
Filed Dec 23, 2024 · 10-Q · 267 days after period end · 0001493152-24-051207
| Metric | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|
| Net Income | $13.00M | -$72.09M | -$165.71K |
| EPS Diluted | $0.48 | -$2.90 | -$0.23 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ocean Biomedical, Inc. · CIK 1869974 · Engraved from SEC EDGAR
ended Mar 31, 2024 · filed Dec 23, 2024 · 267 d after period end
